Skip to main content
Log in

Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis

  • Metabolic Diseases
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The impact of pre-diabetes on clinical status was retrospectively studied in 38 cystic fibrosis (CF) patients with diabetes mellitus (DM) and 38 non-diabetic CF patients (control patients), matched in pairs for age, sex, and chronicPseudomonas aeruginosa lung infection. Quarterly parameters of CF clinical status were collected for 6 years prior to the diagnosis of DM in the index case. Compared to the control patients, decreases in body weight, body mass index (BMI), forced expiratory volume in 1s (FEV1), and forced vital capacity (FVC) and an increase in the daily intake of pancreatic enzyme capsules were found in the pre-diabetic patients. Statistically significant differences in body weight, BMI, FEV1, FVC, and intake of pancreatic enzyme capsules between pre-diabetic and control patients emerged 4, 4, 1.25, 3 and 4.5 years prior to the diagnosis of DM, respectively. The number of lung infections did not differ between the two groups of patients. Thus, when DM develops in CF patients, an insidious decline in overall clinical status is observed for years prior to its diagnosis. Whether clinical deterioration in CF leads to DM, or pre-diabetes results in declining CF clinical status is presently unknown. Accumulating evidence suggests that the latter may be the case since insulin therapy seems to improve lung function in CF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CF:

cystic fibrosis

DM:

diabetes mellitus

BMI:

body mass index

FEV1 :

forced expiratory volume in 1s

FVC:

forced vital capacity

References

  1. Bistritzer T, Sack J, Eshkol A, Katznelson D (1983) Hemoglobin A1 and pancreatic beta cell function in cystic fibrosis. Isr J Med Sci 19:600–603

    PubMed  Google Scholar 

  2. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu S-C, Klein DJ (1988) Diabetes mellitus associated with cystic fibrosis. J Pediatr 112:373–377

    PubMed  Google Scholar 

  3. Frier B, Faber OK, Binder C, Elliott HL (1978) The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia 14:301–304

    PubMed  Google Scholar 

  4. Handwerger S, Roth J, Gorden P, Di Sant'Agnese P, Carpenter DF, Peter G (1969) Glucose intolerance in cystic fibrosis. N Engl J Med 281:451–461

    PubMed  Google Scholar 

  5. Hoskins PJ, Leslie RDG, Pyke DA (1985) Height at diagnosis of diabetes in children: a study in identical twins. BMJ 290:278–280

    PubMed  Google Scholar 

  6. Høiby N (1977)Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance ofPseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Path Microbiol Scand. Section C, Immunology 85 [Suppl 262]:3–96

    Google Scholar 

  7. Høiby N, Pedersen SS (1989) Estimated risk of cross-infection withPseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 78:395–404

    PubMed  Google Scholar 

  8. Johansen HK, Nir M, Høiby N, Koch C, Schwartz M (1991) Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation. Lancet 337:631–634

    PubMed  Google Scholar 

  9. Lange P, Groth S, Kastrup J, Mortensen J, Appleyard M, Nyboe J, Jensen G, Schnohr P (1989) Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 2:14–19

    PubMed  Google Scholar 

  10. Lange P, Groth S, Mortensen J, Appleyard M, Nyboe J, Schnohr P, Jensen G (1990) Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Respir J 3:288–292

    PubMed  Google Scholar 

  11. Lanng S, Schwartz M, Thorsteinsson B, Koch C (1991) Endocrine and exocrine pancreatic function and the ΔF508 mutation in cystic fibrosis. Clin Genet 40:345–348

    PubMed  Google Scholar 

  12. Lanng S, Thorsteinsson B, Nerup J, Koch C (1991) Glucose tolerance in cystic fibrosis. Arch Dis Child 66:612–616

    PubMed  Google Scholar 

  13. Lanng S, Thorsteinsson B, Nerup J, Koch C (1991) Diabetes mellitus and lung function in cystic fibrosis. Diabetes 40 [Suppl 1]:525A

    Google Scholar 

  14. Leslie RDG, Lo S, Millward BA, Honour J, Pyke DA (1991) Decreased growth velocity before IDDM onset. Diabetes 40:211–216

    PubMed  Google Scholar 

  15. Milner AD (1969) Blood glucose and serum insulin levels in children with cystic fibrosis. Arch Dis Child 44:351–355

    PubMed  Google Scholar 

  16. Polgar G, Promadhat V (1971) Pulmonary function testing in children: techniques and standards. WB Saunders, Philadelphia, pp 88–107, 178–182

    Google Scholar 

  17. Reisman J, Corey M, Canny G, Levison H (1990) Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics 86:374–377

    PubMed  Google Scholar 

  18. Rodman HM, Doershuk CF, Roland JM (1986) The interaction of 2 diseases: diabetes mellitus and cystic fibrosis. Medicine 65:389–397

    PubMed  Google Scholar 

  19. Schwartz M, Johansen HK, Koch C, Brandt NJ (1990) Frequency of the ΔF508 mutation on cystic fibrosis chromosomes in Denmark. Hum Genet 85:427–428

    PubMed  Google Scholar 

  20. Stutchfield PR, O'Halloran S, Teale JD, Isherwood D, Smith CS, Heaf D (1987) Glycosylated haemoglobin and glucose intolerance in cystic fibrosis. Arch Dis Child 62:805–810

    PubMed  Google Scholar 

  21. Thorsteinsson B, Lanng S, Nerup J, Koch C (1991) Epidemiology of glucose intolerance in cystic fibrosis. Diabetes 40 [Suppl 1]: 320A

    Google Scholar 

  22. Wilson RM (1991) Infection and diabetes mellitus. In Pickup JC, Williams G (eds) Textbook of Diabetes. Blackwell Scientific Publications, Oxford, pp 813–819

    Google Scholar 

  23. World Health Organization Study Group (1985) Diabetes mellitus. WHO Tech Rep Ser 727:1–113

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lanng, S., Thorsteinsson, B., Nerup, J. et al. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 151, 684–687 (1992). https://doi.org/10.1007/BF01957574

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01957574

Key words

Navigation